NurExone Biologic Inc. Emerges as a Promising Investment Opportunity in Biotechnology
<!-- Name:DistributionId Value:1000782358 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->
<!-- Name:IcbCode Value:4570 -->…
Browsing Tag
NurExone Biologic Inc.
United States Patent Office Allows Patent to Exosome Biomedical Company Nurexone
HAIFA, Israel and CALGARY, Alberta, Jan. 13, 2023 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (NRX:CVE) (J90:FRA) (the “Company” or “NurExone”), a biopharmaceutical company developing biologically-guided exosome therapy (“ExoTherapy”) for…
Medigus: Polyrizon Signed an Agreement with Nurexone for Intranasal Administration of Cutting…
Polyrizon will be entitled for up to $3.35 million in addition to future royalties Tel Aviv, Israel, July 18, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions,…